Skip to main content
. 2021 Apr 7;10(3):224–239. doi: 10.1159/000514400

Table 2.

Reasons for treatment noncompliance to NCCS consensus guidelines recommendations

HCC stage Frequency, n = 120 Reason for treatment noncompliance to NCCS consensus guidelines recommendations
Early Stage HCC 13 − 5, patient or family's decision
− 3, MDTB recommended treatment outside of guidelines
− 5, individual physician decision

Locally advanced-stage HCC 57 − 23, patient or family's decision
− 28, individual physician's decision
− 3, MDTB recommended treatment outside of guidelines
− 1, death before treatment initiation
− 1, rapid disease progression before treatment
− 1, poor tolerance of therapy

Metastatic stage HCC 50 − 31, patient or family's decision
− 1, MDTB recommended treatment outside of guidelines
− 13, individual physician's decision
− 3, rapid disease progression before treatment
− 2, poor tolerance of therapy

MDTB, multidisciplinary tumour board; HCC, hepatocellular carcinoma; NCCS, National Cancer Centre Singapore.